Skip to main content
. 2016 Jun 28;115(2):188–194. doi: 10.1038/bjc.2016.185

Figure 3.

Figure 3

Second-line OS (OS2), defined as survival time from the start of 2L therapy to death, in patients who received 2L therapy. Gem=gemcitabine; HR=hazard ratio; nab-P=nab-paclitaxel.